Linaclotide acetate: Preliminary Phase IIb data

Preliminary data from a 4-week, double-blind, placebo-controlled, U.S. Phase IIb trial in 310 patients showed that linaclotide significantly improved weekly SBM frequency at doses >75 ug. Dose-depende...